ARCHIVES

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

“Start Fighting” Says Former Rep. John Porter To Crowd of 12,000 at AACR Washington Rally

April 12, 2013

NCAB Committee Close To Definition Of QRA

February 11, 1983

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

FDA Proposes Guidelines For Testing New Anticancer Drugs

November 14, 1975

CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown

October 1, 2010

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000